Business & Markets
Companies
Congress
Democrats
drug prices
Economic Policies
Economy
Executive Branch
Health and Human Services
Inflation Reduction Act
Investment
Janssen
Johnson Johnson
Judiciary
Markets
Medicare
Policies & Impacts
Politics
US
US News
J&J Sues Biden Administration to Block Medicare Drug Price Negotiations
Johnson & Johnson corporate headquarters in New Brunswick, N.J., on Nov. 3, 2009. (Mario Tama/Getty Images) Top right: The anti-psychotic drug Risperdal produced by Janssen, a subsidiary of Johnson &…